Telomir Pharmaceuticals, Inc. (TELO): SCHEDULE 13G/A filed Aug 14, 2026

Form type

SCHEDULE 13G/A

Filing date

Aug 14, 2026

Accession number

0001104659-26-097283

Filer

Telomir Pharmaceuticals, Inc. (CIK 1971532)